HR 5763
114th Congress
House
Health
Cancer
Medical tests and diagnostic methods
Medicare
Prostate Cancer Misdiagnosis Elimination Act of 2016
Introduced: July 13, 2016
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 1, 2016
Referred to the Subcommittee on Health.
Jul 13, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 13, 2016
Introduced in House
Plain-English summary
Prostate Cancer Misdiagnosis Elimination Act of 2016
This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3
Cosponsors
1